These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27761545)

  • 1. Stiffness of pancreatic cancer cells is associated with increased invasive potential.
    Nguyen AV; Nyberg KD; Scott MB; Welsh AM; Nguyen AH; Wu N; Hohlbauch SV; Geisse NA; Gibb EA; Robertson AG; Donahue TR; Rowat AC
    Integr Biol (Camb); 2016 Dec; 8(12):1232-1245. PubMed ID: 27761545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells.
    Nguyen AV; Trompetto B; Tan XHM; Scott MB; Hu KH; Deeds E; Butte MJ; Chiou PY; Rowat AC
    Cell Mol Bioeng; 2020 Feb; 13(1):27-44. PubMed ID: 32030106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME)
    Nabavizadeh A; Payen T; Iuga AC; Sagalovskiy IR; Desrouilleres D; Saharkhiz N; Palermo CF; Sastra SA; Oberstein PE; Rosario V; Kluger MD; Schrope BA; Chabot JA; Olive KP; Konofagou EE
    Theranostics; 2020; 10(10):4614-4626. PubMed ID: 32292518
    [No Abstract]   [Full Text] [Related]  

  • 4. Single Cell Mechanotype and Associated Molecular Changes in Urothelial Cell Transformation and Progression.
    Yu W; Lu QY; Sharma S; Ly C; Di Carlo D; Rowat AC; LeClaire M; Kim D; Chow C; Gimzewski JK; Rao J
    Front Cell Dev Biol; 2020; 8():601376. PubMed ID: 33330495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.
    Lian EY; Hyndman BD; Moodley S; Maritan SM; Mulligan LM
    Oncogene; 2020 Oct; 39(41):6493-6510. PubMed ID: 32884116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.
    Verma A; Wang H; Manavathi B; Fok JY; Mann AP; Kumar R; Mehta K
    Cancer Res; 2006 Nov; 66(21):10525-33. PubMed ID: 17079475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
    Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
    Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.
    Jian Z; Cheng T; Zhang Z; Raulefs S; Shi K; Steiger K; Maeritz N; Kleigrewe K; Hofmann T; Benitz S; Bruns P; Lamp D; Jastroch M; Akkan J; Jäger C; Huang P; Nie S; Shen S; Zou X; Ceyhan GO; Michalski CW; Friess H; Kleeff J; Kong B
    Cell Mol Gastroenterol Hepatol; 2018; 6(4):429-449. PubMed ID: 30258965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression.
    Kitaura Y; Chikazawa N; Tasaka T; Nakano K; Tanaka M; Onishi H; Katano M
    Pancreas; 2011 Oct; 40(7):1034-42. PubMed ID: 21697762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
    Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M
    PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
    Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
    Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.
    Muniz VP; Barnes JM; Paliwal S; Zhang X; Tang X; Chen S; Zamba KD; Cullen JJ; Meyerholz DK; Meyers S; Davis JN; Grossman SR; Henry MD; Quelle DE
    Mol Cancer Res; 2011 Jul; 9(7):867-77. PubMed ID: 21636682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
    Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
    Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.